ArticleHeliyon2019

Pre-clinical anti-tumor activity of Bruton's Tyrosine Kinase inhibitor in Hodgkin's Lymphoma cellular and subcutaneous tumor model.

Irfana Muqbil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.